Updates on Advanced Breast Cancer: Local Management and Other New Perspectives

LIVE
Updates on Advanced Breast Cancer: Local Management and Other New Perspectives Banner

Add to Calendar Updates on Advanced Breast Cancer: Local Management and Other New Perspectives 2/27/2026 7:00:00 AM 2/28/2026 1:00:00 PM America/Chicago For More Details: https://mdanderson.cloud-cme.com/ABC2026Conf Description: This activity emphasizes the integration of novel therapies and diagnostic tools into clinical practice, including liquid biopsy, ctDNA, and MRD monitoring for inflammatory breast cancer (IBC). It also explores DDR-targeted strategies, CAR-T therapy limitations, and the role of T-cell receptor and vaccine-based immunotherapies. Experts will highlight interdisciplinary collaboration, including the roles of nurse navig... Houston Marriott Medical Center false MM/DD/YYYY


Date & Location
Friday, February 27, 2026, 7:00 AM - Saturday, February 28, 2026, 1:00 PM, Houston Marriott Medical Center, Houston, TX

Target Audience
Specialties - Complex General Surgical Oncology, Medical Oncology
Professions - Genetic Counselor, Nurse - APRN, Nurse - RN, Other, Pharmacist, Physician (MD or DO), Physician Associate, Social Worker, Student or Trainee

Credits
AMA PRA Category 1 Credits™ (9.25 hours), AAPA Category 1 CME (9.25 hours), ABIM MOC Part 2 (9.25 hours), ABS CC (9.25 hours), ABS CC SAM (9.25 hours), ACPE Contact Hour(s) (9.25 hours), ANCC - Nursing Contact Hour(s) (9.25 hours), Non-Physician Attendance (9.25 hours), Pharmacotherapeutics (9.25 hours), SW - Social Work (3.00 hours)

Overview
This activity emphasizes the integration of novel therapies and diagnostic tools into clinical practice, including liquid biopsy, ctDNA, and MRD monitoring for inflammatory breast cancer (IBC). It also explores DDR-targeted strategies, CAR-T therapy limitations, and the role of T-cell receptor and vaccine-based immunotherapies. Experts will highlight interdisciplinary collaboration, including the roles of nurse navigators, advanced practice providers, and social workers.

Objectives
At the conclusion of this activity, learners will be able to:

  1. Evaluate and apply DDR-targeted and CAR-T strategies in the treatment of advanced breast cancer.
  2. Incorporate ctDNA and MRD monitoring into clinical decision-making for advanced breast cancer patients.
  3. Identify and manage emerging toxicities associated with novel therapies in advanced breast cancercare.
  4. Integrate immunotherapy and vaccine-based approaches into treatment plans for oligometastatic and inflammatory breast cancer.
  5. Enhance interdisciplinary collaboration, including the roles of social workers, advanced practice providers, and nurse navigators to improve patient outcomes.

Registration

Join us for a one-and-a-half-day conference, Updates on Advanced Breast Cancer: Local Management and New Perspectives, taking place at the Marriott Medical Center Hotel Houston (6580 Fannin Street, Houston, TX 77030).

  • Friday, February 27, 2026
    Opening Remarks begin at 8:00 AM, with sessions running through 6:00 PM.

  • Saturday, February 28, 2026
    The conference will reconvene at 7:50 AM and conclude at 1:00 PM.

Advanced registration is encouraged as space is limited. If you are considering attending this conference, please follow the link below to create a profile in PEP prior to registering: https://mdanderson.cloud-cme.com/default.aspx

The deadline for advanced registration is Thursday, Jan. 5, 2026. 




We accept the following forms of payment:

  • Credit Cards (MasterCard, VISA, and American Express)

  • Check made payable to: The University of Texas MD Anderson Cancer Center (payable through U.S. banks only)

Mail to: 
Continuing Professional Education – Unit 1781
The University of Texas MD Anderson Cancer Center
 P.O. Box 301407
 Houston, Texas 77230-1407
Telephone registrations are not accepted

When registering online a receipt (confirmation) will be automatically emailed to the e-mail address you list on the registration form.

Refund/Cancellation Policy The registration fee, minus a $15.00 administration-handling fee, is refundable if a written request is received on or before Thursday, Jan. 29, 2026.  No refunds will be granted after these dates. The request for a registration refund must include the tax identification number of the company or institution if registration was paid by a company or institution check. The Department of Continuing Professional Education (CPE) reserves the right to cancel activities prior to the scheduled date, if low enrollment or other circumstances make it necessary.  Each registrant will be notified by mail, e-mail, or at the phone or fax numbers given on the registration form.  In case of activity cancellation, the liability of CPE, is limited to the registration fee.  CPE will refund the full registration fee. 

CPE reserves the right to limit the number of participants in a program and is not responsible for any expenses incurred by an individual whose registration is not confirmed and for whom space is not available. 

For additional information, contact CPE, at 713-792-2223 or toll free at 866-849-5866 or via e-mail: [email protected].

Special Assistance Contact CPE, at 713-792-2223 or toll free at 866-849-5866 if you have any ADA accommodation needs.


Accreditation

In support of improving patient care, The University of Texas MD Anderson Cancer Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation
The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 9.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The University of Texas MD Anderson Cancer Center designates this live activity will award 9.25 Nursing Contact Hour(s) which includes APRN 9.25 Pharmacotherapeutics credit(s)

AMERICAN BOARD OF INTERNAL MEDICINE (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 9.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participant completion data will be shared with and transmitted to the ACCME on the participant’s behalf.  In order to receive MOC points, you must pass the post-test with a score of 70% or higher. 



The University of Texas MD Anderson Cancer Center has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 9.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

American Board of Surgery (ABS)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

The University of Texas MD Anderson Cancer Center designates this application-based activity for 9.25 hours under UAN JA0004118-0000-25-001-L99-P. Credits will be provided to NABP CPE Monitor within 60 days after the activity completion. Learners must provide their NABP e-profile ID and Date of Birth in their MyCE Profile for credits to be reported to CPE Monitor.

The University of Texas MD Anderson (CEU Provider #4607) is an approved continuing education provider for Social Workers through the Texas State Board of Social Worker Examiners. This activity has been approved for 3.0 continuing education units.

 


Additional Information

View the accessibility policy for The University of Texas MD Anderson Cancer Center.